Anti-miR-34a 3WJ-RNPs

N/A

Report date: 2026/04/10 20:01:49

NME

Base Information

Drug NameAnti-miR-34a 3WJ-RNPs

Drug Alias NameN/A

ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Oligonucleotide aptamerSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > microRNA

Mechanisms of ActionmicroRNA-34a inhibitors

TargetsmicroRNA-34a

Therapy Area/IndicationsRenal Insufficiency, Chronic

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryEgypt

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesUniversity of Alexandria

China Registration ClassN/A

Develop Information

Active CompaniesUniversity of Alexandria Pharos University in Alexandria

Inactive CompaniesN/A

Active IndicationsRenal Insufficiency, Chronic

Inactive IndicationsN/A

Other Information

ATC CodeN/A